Geny Research Corp. Report issue

For profit Phase 4
Founded: Newton Upper Falls MA United States (1999)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2006
NCT00947531
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

cenegermin-bkbj (oxervate) (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dementia (Phase 4)

Dementia, Vascular (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2